Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 200-208

  Liu, Su Hsun ^a,d   Cummings, Derek A T ^a   Zenilman, Jonathan M ^a,b   Gravitt, Patti E ^a,e   Brotman, Rebecca M ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e PERDANA UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

SINGLE STRANDED DNA; VIRUS DNA;

ADULT; ARTICLE; CASUAL SEX; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMICS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SAMPLING; SEXUAL BEHAVIOR; VAGINA SMEAR; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS;

EID: 84892727798     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0666     Document Type: Article

References (33)

1. Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S, O'Reilly S, et al. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev 2011;20:699-707.
2. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3. Int J Cancer 2012;131:1874-81.
3. Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, et al. Incidence, duration and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev 2010;19:1585-94.
4. Weaver B, Shew M, Qadadri B, Tu W, Tong Y, Denski C, et al. Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women. J Med Virol 2011;83:1362-9.
5. Gravitt P. The known unknowns of HPV natural history. J Clin Invest 2011;121:4593-9.
6. Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obs Gyn 2008;198:628.
7. Chen FC, Shaw SW, Cheng PJ, Hsueh S, Lin CT. Diagnosis of human papillomavirus infection by abnormal cervical cytology is highly reproducible after vaginal douching. Taiwanese J Obs Gyn 2008;47:412-6.
8. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012;4:132ra52.
9. Trimble C, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLAP henotype. Clin Cancer Res 2005;11:4717-23.
10. Cleveland WS, McGill R. The many faces of a scatterplot. J Am Stat Assoc 1984;79:807-22.
11. Swihart B, Caffo B, James B, Strand M, Schwartz B, Punjabi N. Lasagna plots: a saucy alternative to spaghetti plots. Epidemiol 2010; 21:621-5.
12. Therneau TM. Multiple events per subject. In: Therneau TM, Grambsch PM, editors. Modeling Survival Data, Extending the Cox Model. New York: Springer-Verlag; 2000. p. 169-229.
13. Pena E, Strawderman R, Hollander M. Nonparametric estimation with recurrent event data. J Am Stat Assoc 2001;96:1299-315.
14. Gonzalez JR, Pena EA. Bootstrapping median survival with recurrent event data. IX Conferencia Espanola de Biometria, La Coruna, May 28-30, 2003 [cited 2013 Nov. 10]. Available from: http://www.udc.es/dep/mate/biometria2003/ Archivos/ot79.pdf.
15. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graphical Stat 1996;5:299-314.
16. StataCorp LP. Stata statistical software. College Station, TX: Stata-Corp LP; 2009.
17. Brown D, Shew M, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92.
18. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82(4 Pt 1):578-85.
19. Crum CP, Beach KJ, Hedley ML, Yuan L, Lee KR, Wright TC, et al. Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol. J Infect Dis 2004;189:1348-54.
20. de Villiers EM, Wagner D, Schneider A, Wesch H, Munz F, Miklaw H, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol 1992;44:33-9.
21. Woodman C, Collins S. A critique of cohort studies examining the role of human papillomavirus infection in cervical neoplasia. Br J Obstet Gynecol 2002;109:1311-8.
22. Woodman C, Collins S, Young L. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22.
23. Widdice L, Ma Y, Jonte J, Farhat S, Breland D, Shiboski S, et al. Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis 2013; 207:1286-94.
24. Grant LA, Dunne EF, Chesson H, Markowitz LE. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine 2011;29:2365-70.
25. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol 2010;117:S5-10.
26. Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res 2012;72:6183-90.
27. Sycuro LK, Xi LF, Hughes JP, Feng Q, Winer RL, Lee SK, et al. Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis 2008; 198:971-8.
28. Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005;81: 207-12.
29. Gravitt P, Belinson J, Salmeron J, Shah K. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011; 129:517-27.
30. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132:2223-36.
31. Schmeink C, Massuger L, Lenselink C, Quint W, Melchers W, Bekkers R. Effect of the menstrual cycle and hormonal contraceptives on human papillomavirus detection in young, unscreened women. Obstet Gynecol 2010;116:67-75.
32. Liu SH, Brotman RM, Zenilman JM, Gravitt PE, Cummings DAT. Menstrual cycle and detectable human papillomavirus in reproductive women: a time series study. J Infect Dis 2013;208:1404-15.
33. Lee JE, Lee S, Lee H, Song Y-M, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS ONE 2013;8:e63514.